BioStock: In-depth partnering discussions for Respiratorius

Lund-based Respiratorius is at a crucial stage with its drug candidate VAL001. In the year-end report, CEO Johan Drott emphasises that finding the right partner and securing an agreement is a process that requires patience. In-depth discussions are currently underway with a potential taker, and BioStock has spoken to Johan to learn more about the progress.  

Read the full article at biostock.se:

https://www.biostock.se/en/2024/02/in-depth-partnering-discussions-for-respiratorius/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se